Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective

Annals of Surgery

Volumn 235, Issue 4, 2002, Pages 466-486

  Poon, Ronnie Tung Ping ^a   Fan, Sheung Tat ^a   Tsang, Flora Hau Fung ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALCOHOL; DOXORUBICIN; GELATIN; IODINATED POPPYSEED OIL;

ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CRYOTHERAPY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPY; LASER; LIVER CELL CARCINOMA; LIVER FUNCTION; MEDICAL DECISION MAKING; MICROWAVE IRRADIATION; PATIENT CODING; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; RETROSPECTIVE STUDY; REVIEW; SAFETY; TRANSPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ATTITUDE OF HEALTH PERSONNEL; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS;

EID: 0036208524     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200204000-00004     Document Type: Review

References (204)

1. Epidemiology of primary liver cancer
2. Rising incidence of hepatocellular carcinoma in the United States
3. Increase in primary liver cancer in the UK, 1979-94
4. Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths
5. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Is there a way? A prospective analysis of our approach
6. Improving survival results after resection of hepatocellular carcinoma. A prospective study of 377 patients over 10 years
7. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection and chemoembolization
8. An analysis of 412 cases of hepatocellular carcinoma at a Western center
9. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
10. Liver transplantation for hepatocellular carcinoma
11. Clinical trials in primary hepatocellular carcinoma: Current status and future directions
12. Review article: Overview of medical treatments in unresectable hepatocellular carcinoma - An impossible meta-analysis?
13. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
14. Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo- controlled trial in 120 patients
15. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study
16. Intra-arterial and intravenous use of 4-epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison
17. Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma
18. Blood supply of early hepatocellular carcinoma
19. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: Need for controlled trials
20. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: Local therapeutic effect and 5-year survival rate
21. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial
22. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
23. Transcatheter arterial embolization in hepatocellular carcinoma
24. Spontaneous rupture of hepatocellular carcinoma
25. Iodized oil in the treatment of hepatocellular carcinoma
26. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma
27. Unresectable hepatocellular carcinoma: Analysis of prognostic factors in transcatheter management
28. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow-up CT and therapeutic results
29. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model
30. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: Comparison of planned periodic chemoembolization and chemoembolization based on tumor response
31. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: A prospective controlled study
32. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence
33. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors
34. Transcatheter arterial chemoembolization for hepatocellular carcinoma
35. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization
36. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
37. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam
38. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors
39. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a Western comparative study in 60 patients
40. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients
41. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma: An Italian experience
42. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
43. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
44. Treatment of unresectable hepatocellular carcinoma with Lipiodol chemoembolization: A multicenter randomized trial
45. Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues
46. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: Four-year follow-up
47. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: Necessity for prospective randomized trial
48. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma
49. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
50. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - Results from a liver transplantation center
51. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors
52. Recurrent hepatocellular carcinoma after partial hepatectomy: Value of treatment with transcatheter arterial chemoembolization
53. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection
54. Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan
55. A pre-operative chemoembolization therapy using Lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma
56. Influence of preoperative transarterial Lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
57. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma
58. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?
59. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
60. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma
61. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma
62. Role of transarterial chemoembolization before liver resection for hepatocarcinoma
63. Liver scintigraphy is useful for selecting candidates for preoperative transarterial chemoembolization among patients with hepatocellular carcinoma and chronic liver disease
64. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma
65. Postoperative adjuvant chemotherapy after radical resection for hepatocellular carcinoma (HCC)
66. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: A randomized controlled trial
67. Multimodality treatment for hepatocellular carcinoma on cirrhosis: The role of chemoembolization and alcoholization before liver transplantation
68. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis but no survival benefit?
69. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study
70. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis
71. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma
72. New effective treatment using proton irradiation for unresectable hepatocellular carcinoma
73. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine-131-labeled Lipiodol
74. Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: Immediate and long-term results
75. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma
76. Superselective intra-arterial radiometabolic therapy with I-131 Lipiodol in hepatocellular carcinoma
77. Small hepatocellular carcinoma: High dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol
78. 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma
79. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support
80. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow
81. Intra-arterial iodine 131-labeled Lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: A phase 2 clinical study
82. Adjuvant intra-arterial iodine-131-labelled Lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
83. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase I and II study
84. Percutaneous ethanol injection under interventional radiographic computed tomography-fluoroscopic guidance for the treatment of small hepatocellular carcinoma
85. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: Evaluation with CT
86. Hepatocellular carcinoma: Use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection
87. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: Evaluation with contrast-enhanced MR imaging
88. Percutaneous ethanol injection for treatment of small hepatocellular carcinoma. Study of 95 patients
89. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: A study on 207 patients
90. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates
91. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study
92. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
93. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection
94. Necrosis of the hepatocellular carcinoma nodule can aggravate metastasis
95. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma
96. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection
97. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients
98. Intratumor ethanol injection therapy for solitary minute hepatocellular carcinoma. A study of 37 patients
99. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients
100. Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group
101. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients
102. Percutaneous ethanol injection treatment in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: A long-term result
103. No treatment resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis
104. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: A retrospective multicenter study
105. Diagnostic imaging and interventional therapy of hepatocellular carcinoma
106. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
107. An analysis of 412 cases of hepatocellular carcinoma at a Western center
108. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis
109. Long-term results of single-session percutaneous ethanol injection in patients with large hepatocellular carcinoma
110. Percutaneous ethanol injection under general anaesthesia for hepatocellular carcinoma: 3-Year survival in 112 patients
111. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: Long-term results in 268 patients
112. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection
113. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection
114. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection
115. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma
116. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma
117. Intratumor ethanol injection
118. Small hepatocellular carcinoma: Treatment with US-guided intratumoral injection of acetic acid
119. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
120. Hepatic cryosurgery
121. Hepatic cryotherapy for liver tumors. Development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use
122. Ultrasound-guided laparoscopic cryoablation of hepatic tumors: Preliminary report
123. MR imaging-guided percutaneous cryotherapy of liver tumors: Initial experience
124. Perivascular and intralesional tissue necrosis after hepatic cryoablation: Results in a porcine model
125. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: Report of 60 cases
126. Is cryosurgical ablation appropriate for treating hepatocellular cancer?
127. Place of cryosurgery in the treatment of malignant liver tumors
128. Cryosurgical ablation of hepatic tumors
129. Management of hepatocellular carcinoma: Long-term outcome in 2639 cases
130. Cryosurgery as a treatment for advanced-stage hepatocellular carcinoma: Results, complications, and alcohol ablation
131. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies
132. Rationale for the combination of cryoablation with surgical resection of hepatic tumors
133. World survey on the complications of hepatic and prostate cryotherapy
134. Hepatic cryosurgery for recurrent hepatocellular carcinoma after hepatectomy: A preliminary report
135. Microwave coagulation therapy on hepatomas: CT and MR appearance after therapy
136. Real-time evaluation of the effectiveness of microwave coagulation therapy for hepatocellular carcinoma using color Doppler imaging
137. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma
138. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma
139. Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience
140. Laparoscopic microwave coagulonecrotic therapy for hepatocellular carcinoma
141. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma
142. Value of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in relation to tumor size and location
143. Microwave coagulation therapy for hepatocellular carcinoma
144. Microwave coagulonecrotic therapy for hepatocellular carcinoma
145. Intraoperative microwave coagulation therapy for large hepatic tumors
146. Intra-operative microwave tissue coagulation as treatment for patients with non-resectable hepatocellular carcinoma
147. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors
148. CT appearance of hepatic tumors after microwave coagulation therapy
149. Microwave coagulation therapy for hepatocellular carcinoma
150. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma. Comparison with percutaneous ethanol injection therapy
151. Importance of eliminating portal flow to produce larger intrahepatic lesions with interstitial laser coagulation
152. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia
153. Laser-induced thermotherapy of malignant liver tumors: General principles, equipment, procedure, side effects, complications and results
154. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: Results in 104 treated patients
155. Technology for radiofrequency thermal ablation of liver tumors
156. Tissue ablation with radiofrequency: Effect of probe size, gauge, duration, and temperature on lesion volume
157. Radiofrequency ablation of porcine liver in vivo: Effects of blood flow and treatment time on lesion size
158. Radiofrequency tissue ablation: Physical principles and techniques for increasing coagulation necrosis
159. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions
160. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer
161. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode
162. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma
163. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a "cooled-tip needle." A preliminary clinical experience
164. Percutaneous US-guided radiofrequency ablation of hepatocellular carcinomas: Results in 15 patients
165. Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumours
166. Laparoscopic radiofrequency thermal ablation of hepatocarcinoma: Preliminary experience
167. Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach
168. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
169. Intra-operative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma
170. Radiofrequency ablation of hepatocellular carcinoma in 110 patients with cirrhosis
171. Radiofrequency ablation of 231 unresectable hepatic turnouts: Indications, limitations and complications
172. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up
173. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma
174. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: Usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response: Preliminary results
175. Small hepatocellular carcinoma: Treatment with radiofrequency ablation versus percutaneous ethanol injection
176. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
177. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results
178. Percutaneous treatment of small hepatocellular carcinoma: Radiofrequency ablation versus percutaneous ethanol injection: A prospective randomised trial (second report)
179. Percutaneous ablation of small hepatocellular carcinoma (HCC): A prospective comparison between percutaneous ethanol instillation (PEI) and radiofrequency (RF) ablation therapy
180. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: A proposed algorithm
181. Comparison of the effects of in-vivo thermal ablation of pig liver by microwave and radiofrequency coagulation
182. Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization
183. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma
184. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - A single-center analysis including 132 patients
185. Treatment of large HCC: Transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization
186. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: Local therapeutic effect and long-term survival rate
187. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization
188. Chemoembolization and percutaneous ethanol injection for intrahepatic recurrence of hepatocellular carcinoma after hepatic resection
189. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma
190. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply
191. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma
192. Hepatocellular carcinoma: Long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization
193. Combined therapy with radiofrequency thermal ablation and intraarterial infusion chemotherapy for hepatic metastases from colorectal cancer
194. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma
195. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma
196. Intraductal cooling of the main bile duct during intraoperative radiofrequency ablation
197. Experimental study of laparoscopic laser-induced thermotherapy for liver tumours
198. Hepatocellular carcinoma treated with radiofrequency ablation: Comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT
199. Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: A preliminary report
200. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation
201. High-intensity focused ultrasound in the treatment of experimental liver tumour
202. CT appearance and its diagnosis value in liver cancer after transcatheter oily chemoembolization combining with high intensity focused ultrasound therapy
203. Focal hepatic ablation using interstitial photon radiation energy
204. Value of three-dimensional US for optimizing guidance for ablating focal liver tumors